Cholesteatoma is a condition in which abnormal skin cells grow in the middle ear and can slowly damage hearing and surrounding structures if left untreated. It is difficult to recognize early, and many patients face a long path to diagnosis. Such was the experience of one of our trainees (an aspiring ear doc):
“In 2022, I developed persistent hearing loss, ringing in my ear, and repeated ear infections. These symptoms were debilitating – disrupting my sleep, concentration, and ability to function as a first-year medical student. After months of uncertainty, I was diagnosed with cholesteatoma, a destructive and often hidden middle ear condition that had already eroded my hearing bones which required reconstruction. I was fortunate to receive a timely diagnosis, as many patients live with symptoms for years before the disease is recognized. Surgery is the primary treatment, but the disease often comes back, leaving many patients, including myself, living with ongoing uncertainty about the need for future intervention.
This experience inspired me to become involved in research to help advance our knowledge of cholesteatoma. However, federal funding for this condition remains limited, leaving key questions about the disease unanswered. Why does cholesteatoma return in some patients but not others? What is happening within the tissue that makes it so destructive? Why does it behave differently from person to person?”
We are launching this fundraising effort to help address these questions.
Your support will directly fund advanced analysis of tissue from cholesteatoma surgeries at Johns Hopkins, helping researchers understand the disease at its most fundamental, cellular level so we can identify new avenues for treatment. As a high-volume center treating patients at every stage of disease, we have a unique opportunity to understand cholesteatoma at its root, what makes it recur, and what biomarkers predict clinical outcomes.
This knowledge will pave the way for more effective treatments, fewer repeat surgeries, and a future with less uncertainty for patients and their families.
Thank you for considering a gift for cholesteatoma research at Johns Hopkins.
